Maze Therapeutics, Inc. · NASDAQ:MAZE

Third Rock Ventures IV, L.P. reported a 13.90% stake in Maze Therapeutics, Inc. (Schedule 13G)

Event Jan 31, 2025 · Filed May 9, 2025

Third Rock Ventures IV, L.P. reported a 13.90% stake in Maze Therapeutics, Inc., 6,073,958 shares, as a passive investor on Jan 31, 2025. Filed May 9, 2025 (Schedule 13G).

Stake
13.90%
Shares
6,073,958
Intent
Passive
What changed
Crossed above 5%
Filed together
6 holders

The filing in full

HolderStakeShares
Third Rock Ventures IV, L.P.13.90%6,073,958
Third Rock Ventures GP IV, L.P.13.90%6,073,958
TRV GP IV, LLC13.90%6,073,958
Third Rock Ventures V, L.P.2.20%950,800
Third Rock Ventures GP V, L.P.2.20%950,800
TRV GP V, LLC2.20%950,800

Source

View original at SEC

Related